Genetron Health brings 22 new research results in the field of cancer to the 2021 American Association for Cancer Research Annual Meeting

Numbering

topic

1464

Enrichment and screening of LFS patients by analyzing TP53 germline mutations of

2252

Genome profiling of thymic carcinoma identifies putative driver mutations in the NF-

2557

Germline mutation landscape in a large cohort of Chines pancreatic cancer patients

0803

Molecular diagnosis and immunotherapy of a rare lung carcinoma patient associated

0422

Sequential targeted therapy and immunotherapy of a BRAF positive metastatic
melanoma patient with BRAF inhibitor vemurafenib, MEK inhibitor cobimetnib and a
novel PD-1 antibody Sintilimab

2183

Genomic profiling of small bowel adenocarcinoma reveals targetable mutations in
multiple signaling pathways

2217

More somatic mutations can be detected in cerebrospinal fluid ctDNA of NSCLC
patients with brain metastases

2182

Evaluation of somatic and germline mutations in ampullary carcinoma reveals
actionable targets in multiple signaling pathways

1209

An effective treatment for recurrent and inoperable anaplastic thyroid carcinoma
using sintilimab and anlotinib: a case report

1681

Correlation of BRCA1/2 mutations with response to immune checkpoint inhibitors in
colorectal cancer

1641

The predictive values ​​of ARID1A mutations for response to immune checkpoint
inhibitors are varied in different types of solid tumors

1639

Correlation of KMT2C/D loss-of-function mutations with PD-L1 expression and
response to immune checkpoint inhibitors in solid tumors

1640

Correlations of DNA damage response gene alterations with response to immune
checkpoint inhibitors are different in solid tumors

2288

Identification of gene fusions in soft tissue sarcoma improved by integrative DNA
and RNA sequencing

2163

Molecular characteristics of CDK4 and/or MDM2 amplification in Chinese soft tissue
sarcoma (STS) patients

0625

Co-amplification of CDK4 and MDM2 plus HMGA2 fusion in a patient with myogenic
differentiation dedifferentiated liposarcoma

2223

Distinct genomic features of cutaneous, acral and mucosal melanomas in a Chinese
retrospective cohort

2216

Exploration of the genomic features of pan-neuroendocrine tumors in a Chinese
retrospective analysis

2215

Landscape of RET fusion identified by next–generation sequencing in a Chinese
multi-cancer retrospective analysis

1199

Mosaic KRAS G12S mutation associates with poor outcome in papillary thyroid
carcinoma: A case report

2080

Tumor microsatellite instability detection method using paired tumor-normal
sequence data

2313

The characteristics of ERBB2 exon 20 insertion in a large cohort of Chinese NSCLC
patients